Based on the results of core signaling analyses and considering relative protein/gene expression levels of COVID-19-associated ARDS as compared with normal nasopharyngeal human tissues [58], we selected GRP78, FTO, and BECN1 as essential biomarkers (drug targets) of specific etiologic mechanisms for COVID-19-associated ARDS. This evidence concerns the gene FTO and COVID-19.